See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638287_2021_NeuroBo_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001638287')"} |
info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 10, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638287, NeuroBo Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 10,683,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 155,000 |
3 | remainder_Assets | 130,000 |
4 | LiabilitiesCurrent | 3,695,000 |
5 | LiabilitiesNoncurrent | 70,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 7,846,000 |
9 | ResearchAndDevelopmentExpense | 21,870,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 38,000 |
13 | remainder_ComprehensiveNetIncome | 2,000 |
yvar | yval | |
---|---|---|
0 | Assets | 10,968,000 |
1 | Liabilities | 3,765,000 |
2 | Expenses | 29,716,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 7,203,000 |
5 | NetIncome | -29,678,000 |
6 | ComprehensiveNetIncome | -29,677,000 |
7 | BaseVar | 22,244,500 |
8 | EconomicCapitalRatio | -2.35 |